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Previewsas well as perception consistency across
individuals. An overly strong capability of
pattern completion would deny an animal
its ability to discriminate different odor-
ants. Excessive plasticity would lead an
animal to perceive the same object differ-
ently after an unreasonably short period.
Similarly, completely random connections
would make it difficult to generate consis-
tent perception across individuals, so that
fruits may no longer consistently smell
‘‘fruity’’ to human individuals. The connec-
tions in the piriform cortex must be care-
fully carved to achieve a delicate balance
among different behavioral needs. The
wiring stochasticism in the piriform cortex
highlights the needs and challenges of
searching for logic in the neural circuits
underlying animals’ amazing sense of
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In this issue of Neuron, Greenberg and colleagues revise our understanding of how activity-dependent
MeCP2 phosphorylation regulates distinct aspects of brain development and circuit function. The study
also suggests a prominent role for MeCP2 in the regulation of global chromatin state in vivo.MeCP2 (X-linked methyl-CpG-binding
protein 2) is an abundant nuclear protein
that binds methylated DNA and histori-
cally has been thought to act as a tran-
scriptional repressor critical for normal
neural development. Mutations in the
gene encoding MeCP2 cause the Autism-
spectrum disorder Rett Syndrome (RTT).
In this issue ofNeuron, Cohen, Greenberg,
and colleagues demonstrate that activity-
induced phosphorylation of MeCP2 at a
single serine residue (S421) controls dis-
tinct aspects of synapse development
and social behavior (Cohen et al., 2011).
In contrast to prior studies implicating
this phosphorylation event in the dynamic
regulation of MeCP2 binding at specific
promoters, the present study suggests
that the primary function of MeCP2 inneurons is not to regulate transcription of
specific genes but rather to regulate chro-
matin remodeling on a global scale.
DNAmethylation is an epigenetic modi-
fication that plays an essential role in
mammalian embryogenesis presumably
through repressive effects on gene tran-
scription. Functional studies have demon-
strated that methylation of DNA can
inhibit transcription by either blocking
transcription factor access to target re-
gions or by acting as homing sites for
methyl-CpG binding domain proteins
(MBDs) (Bird, 2002). Interest in DNAmeth-
ylation and nervous system develop-
ment took an unprecedented turn over a
decade ago when Zoghbi and colleagues
first identified independent mutations in
the MBD and transcriptional repressiondomains of the human MECP2 gene as
disease-causing mutations leading to
RTT (Amir et al., 1999). Rett syndrome is
a progressive and debilitating neurodeve-
lopmental disorder that predominantly
affects young girls at an estimated
1–10,000–15,000 ratio. Mice that lack
MeCP2 either globally or conditionally in
the central nervous system develop
symptoms similar to RTT (Chen et al.,
2001; Guy et al., 2001). If MeCP2 func-
tions as a transcriptional repressor, then
the identification of genes dependent
upon MeCP2 for proper transcriptional
regulation should provide insight into
the pathophysiology of RTT. Numerous
groups attempted to answer this ques-
tion by examining global transcriptional
profiles from forebrain, hypothalamus, or72, October 6, 2011 ª2011 Elsevier Inc. 3
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Previewscerebellum of MeCP2-deficient mice
using oligonucleotide technology. Sur-
prisingly, they found only subtle changes
in gene expression, throwing the conven-
tional thought of MeCP2 as a transcrip-
tional regulator into question (e.g., Tudor
et al., 2002).
In vitro studies have provided the most
compelling argument for MeCP2 acting
as a transcriptional repressor critical for
central nervous system development and
function. The picture described inmultiple
reports is as follows. MeCP2 is initially
tightly bound to methylated cytosines
within the brain-derived neurotrophic
factor (BDNF) promoter. Membrane de-
polarization triggers calcium-dependent
phosphorylation and subsequent release
of MeCP2 from its DNA bound state. This
releases associated corepressors, allows
chromatin remodeling, and permits sub-
sequent activity-dependent transcription
to occur (Chen et al., 2003; Martinowich
et al., 2003). Using tandem mass spec-
trometry, phosphospecific antibodies, and
elegant biochemical as well as lentiviral
assays, the Greenberg lab previously
identified a key activity-dependent phos-
phorylation site of MeCP2 and analyzed
its role in nervous system development
(Zhou et al., 2006). They demonstrated
that neuronal activity drives phosphoryla-
tion of MeCP2 at serine 421 in a CamKII-
dependentmanner specifically in thebrain
and provided evidence that this single
phospho-event is a mediator of activity-
dependent dendritic growth, spine mat-
uration and BDNF expression. If S421
phosphorylation relaxes the transcrip-
tional repressor effects of MeCP2 on a
select population of activity-dependent
genes necessary for nervous system
development and function, what are the
in vivo effects of blocking this event
and how might they contribute to the
neurobehavioral abnormalities associated
with RTT?
To address these issues, in this study
Greenberg and colleagues generated a
knock-in mouse in which MeCP2 S421
was mutated to an alanine (MeCP2
S421A) thus preventing activity-depen-
dent phosphorylation of this residue. To
investigate the contribution of MeCP2
S421 phosphorylation in cortical circuit
formation, the authors examined dendritic
morphology of cortical neurons both
in vitro and in vivo from MeCP2 S421A4 Neuron 72, October 6, 2011 ª2011 Elseviermutant animals. Mutant cortical neurons
exhibited significantly more dendritic
branches and notably, this increase in
dendritic complexity was found only in
the apical dendritic tufts of pyramidal
neurons. This finding however, differs
from the reduced spine number and den-
dritic complexity reported in studies of
MeCP2 KO null and RTT patients (Na
and Monteggia, 2011). Previous work in
MeCP2 null mice showed reduced cor-
tical activity due to a shift in the bal-
ance between excitation and inhibition in
layer 5 pyramidal neurons. Specifically,
reduced circuit excitability was accompa-
nied by both reduced spontaneous excit-
atory synaptic input and increased inhibi-
tion, however the molecular mechanisms
which underlie this shift remain largely
unknown (Dani et al., 2005). What then,
are the neurophysiological consequences
of activity-dependent MeCP2 S421 phos-
phorylation and does this modification
influence normal synaptic function and
behavior? To address this issue, Cohen
et al. (2011) analyzed spontaneous min-
iature inhibitory postsynaptic currents
(mIPSCs) and spontaneous miniature ex-
citatory postsynaptic currents (mEPSCs)
in whole-cell recordings from layer II/III
pyramidal neurons from MeCP2 S421A
mutant animals and control littermates.
They observed a modest increase in the
amplitude of mIPSCs but no difference
in either the amplitude or frequency of
mEPSCs. Noting that a hallmark of the
early stages of RTT is decreased social
function, the authors next examined the
behavioral responses of animals in which
activity-dependent MeCP2 S421 phos-
phorylation was abolished. Unlike ani-
mals with complete loss of function of
MeCP2, MeCP2 S421A animals do not
exhibit abnormalities in social interaction,
motor coordination, spatial learning, or
memory paradigms, but they are unable
to distinguish between novel and familiar
stimuli. These findings demonstrate a
role for activity-dependent phosphoryla-
tion of MeCP2 S421 in highly specific
and subtle aspects of cortical neu-
ronal morphology, synaptic function, and
behaviors.
Adrian Bird and colleagues have chal-
lenged the view that MeCP2 functions as
a gene-specific transcriptional repressor
(Skene et al., 2010). Using a newly devel-
oped biochemical fractionation tech-Inc.nique, they reported that MeCP2 protein
is almost as abundant as the number of
histone octamers. They employed bisul-
fite sequencing and MeCP2 chromatin-
immunoprecipitation assays followed by
high throughput sequencing (ChIP-Seq)
of mouse brain nuclei extract and discov-
ered that MeCP2 is globally distributed
across the entire mouse genome and
this distribution tracks the density of
methyl-CpGs. In the absence of MeCP2,
they found elevated levels of histone H3
acetylation (H3Ac), linker histone H1, and
transcriptional noise from repetitive ele-
ments, but transcriptional levels of spe-
cific genes remained unchanged (Skene
et al., 2010). These results suggested
that high levels of neuronal MeCP2 func-
tion to affect global chromatin structure
in a genome-wide manner.
One plausible model then is that
MeCP2 is bound across the neuronal
genome and that activity-dependent
phosphorylation of MeCP2 S421 occurs
at specific regulatory elements of genes
which modulate nervous system develop-
ment. To address this issue, Cohen and
collaborators performed MeCP2 ChIP-
Seq with a newly generated pan-MeCP2
antibody and confirmed the observations
of Skene et al. that MeCP2 protein is
broadly distributed across the neuronal
genome with a binding pattern similar to
that of histone H3. Next, the authors com-
pared genome binding profiles of MeCP2
before and after neuronal stimulation in
neuronal cultures and made the unex-
pected discovery that MeCP2 remains
tightly associated with methylated DNA
throughout the neuronal genome regard-
less of neuronal activation. They also con-
firmed a similarly widespread pattern of
MeCP2 phosphorylation, closely tracking
total bound MeCP2 in vivo. If MeCP2
remains constitutively bound to methyl-
ated DNA, doesMeCP2 S421 phosphory-
lation effect activity-dependent trans-
criptional programs? To address this
question, the authors employed ChIP-
qPCR, ChIP-Seq, and oligonucleotide
arrays and, contrary to previous results
from in vitro studies, found that induction
of activity-dependent genes such as Bdnf
and c-fos remained unchanged regard-
less of MeCP2 S421 phosphorylation.
Furthermore they discovered that this
phosphorylation event occurs broadly
across the genome in response to
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for MeCP2 S421 phosphorylation as a
regulator of activity-dependent gene tran-
scription. These results suggest that
MeCP2 functions not as a transcriptional
repressor of a specific subset of genes
but rather as a core component of chro-
matin whose activity-induced phosphory-
lation at a single serine residue controls
distinct aspects of nervous system devel-
opment and function. Aberrations in this
processmay contribute to the pathophys-
iology of RTT. Interpretation of the effects
of MeCP2 phosphorylation are compli-
cated, however, because phosphoryla-
tion occurs at multiple sites which could
have different effects on MeCP2 binding
and/or activity. A recent study generated
a double phosphomutant at S421 and an
additional nearby site (S424) and found
very different phenotypes, reminiscent of
someof the effects ofMeCP2 overexpres-
sion (Li et al., 2011). This study, like prior
studies of MeCP2 phosphorylation, used
ChIP at specific promoters and found
enhanced occupancy. However Cohen
et al. (2011) and Skene et al. (2010) have
failed to find selective binding at pro-
moters using ChIP-Seq, raising the possi-
bility of differential sensitivity between
these assays.
The present study combines an elegant
targeted and specific manipulation in vivo
and a detailed profile of MeCP2 binding
across the genome, as revealed by ChIP
Seq and suggests a more global view of
how tight control of MeCP2 activity must
be ensured to control proper brain devel-
opment. Yet the field as a whole hasraised as many questions as it has an-
swered, and an increasingly complex
and often discordant view ofMeCP2 func-
tion is emerging. For example, MeCP2,
previously thought to have effects pri-
marily on excitatory synaptic transmis-
sion, now appears to play an important
role in inhibitory transmission, and knock-
ing out MeCP2 in all inhibitory neurons
produces many of the same phenotypes
seen in the germline null (Chao et al.,
2010). Unlike the phosphomutant, the
knockout produces decreased, rather
than increased inhibitory input to L2/3
cortical pyramidal neurons. Other studies
have suggested that MeCP2 action, in-
itially thought to function primarily in neu-
rons, also has critical functions in glia, and
that specific disruption of MeCP2 in glia
causes neuronal phenotypes (Lioy et al.,
2011). Together, these studies raise the
possibility that MeCP2 has both global
and local roles. It may play an important
part in the maintenance of chromatin in-
tegrity inmany cell types, but also perform
more local functions in regulating subsets
of genes in specific cell types. We can
only hope that the kind of targeted in vivo
manipulation performed by Cohen et al.
(2011) coupled to highly discriminating
analyses of neuronal and behavioral phe-
notypes will help resolve this apparent
local/global confusion.REFERENCES
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